Cancer microRNAs: from subtype profiling to predictors of response to therapy

Elcie Chan1, Daniel Estévez Prado, Joanne Barnes Weidhaas

  • 1Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510, USA.

Insights

MicroRNAs (miRNAs) are crucial gene regulators implicated in cancer. Understanding miRNA expression in tumors offers new avenues for cancer diagnosis, risk assessment, and therapy response prediction.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) are vital gene expression regulators.
  • Aberrant miRNA expression is a hallmark of various cancer types.
  • miRNAs can function as oncogenes or tumor suppressors.

Purpose of the Study:

  • To explore the role of dysregulated miRNAs in characterizing tumor environments.
  • To identify novel oncogenic pathways through miRNA analysis.
  • To investigate the potential of miRNAs as biomarkers for cancer risk, diagnosis, and therapy response.

Main Methods:

  • Analysis of miRNA expression profiles in cancer.
  • Correlation of miRNA expression with cancer phenotypes.
  • Evaluation of miRNA profiling for clinical applications.

Main Results:

  • Dysregulated miRNAs can characterize tumor microenvironments.
  • miRNA profiling holds promise for identifying oncogenic pathways.
  • miRNAs show potential as biomarkers for cancer detection and treatment outcomes.

Conclusions:

  • Altered miRNA expression is a significant feature of cancer.
  • miRNA profiling offers a powerful tool for cancer research and clinical applications.
  • Further understanding of miRNA-cancer associations will advance personalized oncology.